Tranzactioneaza Antibe Therapeutics (CA.ATE) - 0.1476 CAD (%) Tranzactioneaza

1D
1W
1M
3M
6M
1Y
5Y
Max

Indici

Bid 0.1469 CAD
Ask 0.4487 CAD
Minim 0.1476 CAD
Maxim 0.1476 CAD
Pret referinta 0.1476
Volum -
Volum ultima zi 1
Max 52 sapt 1.2300 CAD
Min 52 sapt 0.1476 CAD

Descriere companie

Antibe Therapeutics Inc. (http://www.antibethera.com/) is a commercial-stage pharmaceutical company. The Company is focused on pain, inflammation, and regenerative medicine. The Company’s products pipeline includes Otenaproxesul, ATB-352, and ATB-340. Otenaproxesul is a novel anti-inflammatory drug that releases hydrogen sulfide and combines hydrogen sulfide with naproxen, non-steroidal, anti-inflammatory drug. ATB-352 is a hydrogen sulfide-releasing derivative of ketoprofen. ATB-340 is a gastrointestinal-safe version of low-dose aspirin for cardiovascular and cancer protection. The Company, through its wholly owned subsidiary, Citagenix Inc. (Citagenix) is a seller of tissue regenerative products servicing the orthopaedic and dental marketplaces. Citagenix’s portfolio consists of branded biologics and medical devices that promote bone regeneration.

Informatii companie

Nume

Antibe Therapeutics Inc.

Buna ziua, sunt TreVi. Spuneti-mi, va rog, cu ce informatii va pot fi de folos.